So, corresponding to the three stages of arrhythmias induced by MI, anti-inflammatory methods through inhibiting the effects of cytokines like TNF-α, IL-6, and IL-1β, can reduce the occurrence of VAs in Stage I and Stage II by ameliorating the re-entry mechanism and abnormal automaticity, meanwhile the susceptibility to arrhythmias in Stage III is also reduced due to the improvement in fibrosis. This evidence concerns the gene IL6 and cardiac arrhythmia.